Infrapyloric and Greater Curvature Lymph Node Metastasis in Colon Cancer
Infrapyloric (No.206) and Greater Curvature (No.204) Lymph Node Metastasis in Adenocarcinoma Located at Hepatic Flexure and Right Half of Transverse Colon
1 other identifier
observational
432
1 country
1
Brief Summary
The infrapyloric (No.206) and greater curvature (No.204) lymph node metastasis in adenocarcinoma located at hepatic flexure and right half of transverse colon has not been well discribed and analysed. The aim of this study is to assess the rate of this lymph node metastasis and to reveal its prognostic value for colon cancer located at hepatic flexure and right half of transverse colon. Meanwhile, we can evaluate the safety and feasibility of this extented lymphadenectomy in right hemi-colectomy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 2, 2019
CompletedFirst Posted
Study publicly available on registry
May 3, 2019
CompletedStudy Start
First participant enrolled
October 20, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2026
ExpectedMarch 7, 2024
March 1, 2024
3.8 years
May 2, 2019
March 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
metastasis rate
metastasis rate of infrapyloric (No.206) and greater curvature (No.204) lymph node
an average of 1 year
Secondary Outcomes (4)
lymphadenectomy time
an average of 1 year
intraoperative complication
an average of 1 year
postoperative complication
an average of 1 year
3-year DFS
an average of 3 years
Eligibility Criteria
Patients hospitalized in Shanghai Minimally Invasive Surgery Center
You may qualify if:
- Age between 18 and 75 years
- American Society of Anesthesiologists (ASA) score I to III
- A biopsy proven histological diagnosis of colorectal carcinoma
- tumor located at hepatic flexure and right half of transverse colon
- Undergoing right hemi-colectomy with extented lymphadenectomy of infrapyloric (No.206) and greater curvature (No.204) lymph node
- Preoperative staging cT2-4aN0M0 or cTanyN+M0
- Willing to participate and informed consent signed
You may not qualify if:
- Pregnant or lactating women
- Synchronous colorectal carcinoma
- History of colorectal cancer or other malignant tumors
- Clinical evidence of metastasis
- Preoperative staging cT1N0 or cT4bNany
- Emergency procedure
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ruijin hospital
Shanghai, Shanghai Municipality, 200025, China
Related Publications (1)
Yalikun A, Cai Z, Hong HJ, Dai K, Li S, Kwan W, Ma J, Feng B, Lu A, Zheng M, Zang L. Infrapyloric (No. 206) and greater curvature (No. 204) lymph node metastasis in adenocarcinoma located in the right half of the transverse colon (InCLART Study): protocol for a multicentre prospective observational study. BMJ Open. 2023 Feb 21;13(2):e066981. doi: 10.1136/bmjopen-2022-066981.
PMID: 36810166DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 2, 2019
First Posted
May 3, 2019
Study Start
October 20, 2019
Primary Completion
August 1, 2023
Study Completion (Estimated)
August 1, 2026
Last Updated
March 7, 2024
Record last verified: 2024-03